Objective: This study aimed to reveal the effects of polycystic ovary syndrome (PCOS) on quality of life, anxiety, eating behavior, and sexual functions, and the relationships or interactions of these factors with each other. Material and Methods: This cross-sectional study was performed in women diagnosed with PCOS. Sexually active 54 participants (28 with PCOS + 26 control) aged 22–35 years applying to the gynecology outpatient clinics due to menstrual irregularities were included in the study. The diagnosis of PCOS was made according to the Rotterdam 2003 criteria. Participants filled out data collection forms, including the Beck Anxiety Inventory (BAI), the Short-Form-36 (SF-36) Health Survey, the Three-Factor Eating Questionnaire, and the Female Sexual Function Index. Laboratory findings were obtained from the hospital’s electronic patient registry. Results: The PCOS group’s BMI (29.6±7.1) was significantly higher than the control group (24.7±3.9), (p=0.004)). The PCOS group scores were significantly lower than the control group regarding the physical functionality (p=0.006), role limitations due to emotional problems (p=0.002), energy/fatigue (p=0.015), and emotional well-being (p=0.025) items of the short-form health survey. In addition, BAI score was higher (p=0.001), and female sexual function index total score was lower (p=0.036) in the PCOS group. There were significant correlations between luteinizing hormone (LH) and role limitations due to emotional problems (r=0.547, p=0.003), uncontrolled eating (r=0.415, p=0.028), emotional eating (r=0.413, p=0.029), and body mass index (r=0.487, p=0.009). Conclusion: PCOS can cause anxiety, decreased quality of life, and increased anxiety, but it does not affect eating disorders. LH levels should be taken into account for weight control in women with PCOS. Women with menstrual irregularities need support concerning anxiety, even if they do not have PCOS. "> [PDF] Anxiety, quality of life, eating behaviors, and sexual life in women with polycystic ovary syndrome | [PDF] Anxiety, quality of life, eating behaviors, and sexual life in women with polycystic ovary syndrome Objective: This study aimed to reveal the effects of polycystic ovary syndrome (PCOS) on quality of life, anxiety, eating behavior, and sexual functions, and the relationships or interactions of these factors with each other. Material and Methods: This cross-sectional study was performed in women diagnosed with PCOS. Sexually active 54 participants (28 with PCOS + 26 control) aged 22–35 years applying to the gynecology outpatient clinics due to menstrual irregularities were included in the study. The diagnosis of PCOS was made according to the Rotterdam 2003 criteria. Participants filled out data collection forms, including the Beck Anxiety Inventory (BAI), the Short-Form-36 (SF-36) Health Survey, the Three-Factor Eating Questionnaire, and the Female Sexual Function Index. Laboratory findings were obtained from the hospital’s electronic patient registry. Results: The PCOS group’s BMI (29.6±7.1) was significantly higher than the control group (24.7±3.9), (p=0.004)). The PCOS group scores were significantly lower than the control group regarding the physical functionality (p=0.006), role limitations due to emotional problems (p=0.002), energy/fatigue (p=0.015), and emotional well-being (p=0.025) items of the short-form health survey. In addition, BAI score was higher (p=0.001), and female sexual function index total score was lower (p=0.036) in the PCOS group. There were significant correlations between luteinizing hormone (LH) and role limitations due to emotional problems (r=0.547, p=0.003), uncontrolled eating (r=0.415, p=0.028), emotional eating (r=0.413, p=0.029), and body mass index (r=0.487, p=0.009). Conclusion: PCOS can cause anxiety, decreased quality of life, and increased anxiety, but it does not affect eating disorders. LH levels should be taken into account for weight control in women with PCOS. Women with menstrual irregularities need support concerning anxiety, even if they do not have PCOS. ">

Anxiety, quality of life, eating behaviors, and sexual life in women with polycystic ovary syndrome

Anxiety, quality of life, eating behaviors, and sexual life in women with polycystic ovary syndrome

Objective: This study aimed to reveal the effects of polycystic ovary syndrome (PCOS) on quality of life, anxiety, eating behavior, and sexual functions, and the relationships or interactions of these factors with each other. Material and Methods: This cross-sectional study was performed in women diagnosed with PCOS. Sexually active 54 participants (28 with PCOS + 26 control) aged 22–35 years applying to the gynecology outpatient clinics due to menstrual irregularities were included in the study. The diagnosis of PCOS was made according to the Rotterdam 2003 criteria. Participants filled out data collection forms, including the Beck Anxiety Inventory (BAI), the Short-Form-36 (SF-36) Health Survey, the Three-Factor Eating Questionnaire, and the Female Sexual Function Index. Laboratory findings were obtained from the hospital’s electronic patient registry. Results: The PCOS group’s BMI (29.6±7.1) was significantly higher than the control group (24.7±3.9), (p=0.004)). The PCOS group scores were significantly lower than the control group regarding the physical functionality (p=0.006), role limitations due to emotional problems (p=0.002), energy/fatigue (p=0.015), and emotional well-being (p=0.025) items of the short-form health survey. In addition, BAI score was higher (p=0.001), and female sexual function index total score was lower (p=0.036) in the PCOS group. There were significant correlations between luteinizing hormone (LH) and role limitations due to emotional problems (r=0.547, p=0.003), uncontrolled eating (r=0.415, p=0.028), emotional eating (r=0.413, p=0.029), and body mass index (r=0.487, p=0.009). Conclusion: PCOS can cause anxiety, decreased quality of life, and increased anxiety, but it does not affect eating disorders. LH levels should be taken into account for weight control in women with PCOS. Women with menstrual irregularities need support concerning anxiety, even if they do not have PCOS.

___

  • 1. Azziz R. Polycystic ovary syndrome. Obstet Gynecol 2018;132:321–36.
  • 2. Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod 2016;31:2841–55.
  • 3. Barthelmess EK, Naz RK. Polycystic ovary syndrome: Current status and future perspective. Front Biosci (Elite Ed) 2014;6:104–19.
  • 4. Damone AL, Joham AE, Loxton D, Earnest A, Teede HJ, Moran LJ. Depression, anxiety and perceived stress in women with and without PCOS: A community-based study. Psychol Med 2019;49:1510–20.
  • 5. Lin AW, Lujan ME. Comparison of dietary intake and physical activity between women with and without polycystic ovary syndrome: A review. Adv Nutr 2014;5:486–96.
  • 6. Altieri P, Cavazza C, Pasqui F, Morselli AM, Gambineri A, Pasquali R. Dietary habits and their relationship with hormones and metabolism in overweight and obese women with polycystic ovary syndrome. Clin Endocrinol 2013;78:52–9.
  • 7. Thannickal A, Brutocao C, Alsawas M, Morrow A, Zaiem F, Murad MH, et al. Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): A systematic review and meta‐analysis. Clin Endocrinol 2020;92:338–49.
  • 8. Chadha C, Kataria J, Chugh P, Choudhary A. Quality of life in young adult females with PCOS. Indian J Physiother Occup Ther 2019;1:40–2.
  • 9. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guildelines for reporting observational studies. J Clin Epidemiol 2008;61:344–9.
  • 10. Dokras A, Stener-Victorin E, Yildiz BO, Li R, Ottey S, Shah D, et al. Androgen excess-polycystic ovary syndrome society: Position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril 2018;109:888–99.
  • 11. Moghadam ZB, Fereidooni B, Saffari M, Montazeri A. Measures of health-related quality of life in PCOS women: A systematic review. Int J Womens Health 2018;10:397–408.
  • 12. Sánchez-Ferrer ML, Adoamnei E, Prieto-Sánchez MT, Mendiola J, Corbalán-Biyang S, Moñino-García M, et al. Health-related quality of life in women with polycystic ovary syndrome attending to a tertiary hospital in Southeastern Spain: A case-control study. Health Qual Life Outcomes 2020;18:232.
  • 13. Tzalazidis R, Oinonen KA. Continuum of symptoms in polycystic ovary syndrome (PCOS): Links with sexual behavior and unrestricted sociosexuality. J Sex Res 2020:1–13.
  • 14. Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod 2011;26:2442–51.
  • 15. Veltman-Verhulst SM, Boivin J, Eijkemans MJ, Fauser BJ. Emotional distress is a common risk in women with polycystic ovary syndrome: A systematic review and meta-analysis of 28 studies. Hum Reprod Update 2012;18:638–51.
  • 16. Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod 2017;32:1075–91.
  • 17. Yu M, Han K, Nam GE. The association between mental health problems and menstrual cycle irregularity among adolescent Korean girls. J Affect Disord 2017;210:43–8.
  • 18. Copp T, Hersch J, Muscat DM, McCaffery KJ, Doust J, Dokras A, et al. The benefits and harms of receiving a polycystic ovary syndrome diagnosis: A qualitative study of women’s experiences. Hum Reprod Open 2019;2019:hoz026.
  • 19. Holton S, Papanikolaou V, Hammarberg K, Rowe H, Kirkman M, Jordan L, et al. Fertility management experiences of women with polycystic ovary syndrome in Australia. Eur J Contracept Reprod Heal Care 2018;23:282–7.
  • 20. Rofey DL, Szigethy EM, Noll RB, Dahl RE, Lobst E, Arslanian SA. Cognitive-behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: A pilot study. J Pediatr Psychol 2009;34:156–63.
  • 21. McCuen-Wurst C, Ruggieri M, Allison KC. Disordered eating and obesity: Associations between binge-eating disorder, night-eating syndrome, and weight-related comorbidities. Ann N Y Acad Sci 2018;1411:96–105.
  • 22. Jeanes YM, Reeves S, Gibson EL, Piggott C, May VA, Hart KH. Binge eating behaviours and food cravings in women with polycystic ovary syndrome. Appetite 2017;109:24–32.
  • 23. Lee I, Cooney LG, Saini S, Smith ME, Sammel MD, Allison KC, et al. Increased risk of disordered eating in polycystic ovary syndrome. Fertil Steril 2017;107:796–802.
  • 24. Coffey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: A comparison with the general population using the polycystic ovary syndrome questionnaire (PCOSQ) and the short form-36 (SF-36). Gynecol Endocrinol 2006;22:80–6.
  • 25. Borghi L, Leone D, Vegni E, Galiano V, Lepadatu C, Sulpizio P, et al. Psychological distress, anger and quality of life in polycystic ovary syndrome: Associations with biochemical, phenotypical andsocio-demographic factors. J Psychosom Obstet Gynecol 2018;39:128–37.
  • 26. Bazarganipour F, Taghavi SA, Montazeri A, Ahmadi F, Chaman R, Khosravi A. The impact of polycystic ovary syndrome on the health-related quality of life: A systematic review and meta-analysis. Iran J Reprod Med 2015;13:61.
  • 27. Yin X, Ji Y, Chan CL, Chan CH. The mental health of women with polycystic ovary syndrome: A systematic review and meta-analysis. Arch Womens Ment Health 2020;24(1):11–27.
  • 28. Pastoor H, Timman R, de Klerk C, Bramer WM, Laan ET, Laven JSE. Sexual function in women with polycystic ovary syndrome: A systematic review and meta-analysis. Reprod Biomed Online 2018;37:750–60.
  • 29. Mitchell KR, Geary R, Graham CA, Datta J, Wellings K, Sonnenberg P, et al. Painful sex (dyspareunia) in women: Prevalence and associated factors in a British population probability survey. BJOG 2017;124:1689–97.
  • 30. Pelanis R, Mellembakken JR, Sundström-Poromaa I, Ravn P, Morin-Papunen L, Tapanainen JS, et al. The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS. Hum Reprod 2017;32:2279–86.